Unlocking Breakthroughs: The Latest Clinical Trial Outcomes Shaping the Future of Myelofibrosis
Webinar/Online
Tuesday, July 22, 2025 at 2:00pm ET - 2:30pm ET
Add this event to your calendar
Info
Topic
The treatment landscape for myelofibrosis (MF) continues to evolve, with several novel therapies in clinical trials displaying disease-modifying potential to alter the underlying disease biology of MF and thereby prolong survival. In the final webinar of the series, expert faculty will discuss the latest evidence from clinical trials in MF to support learners in differentiating novel therapies based on molecular target, clinical data, and potential positioning in care. Don't miss your opportunity to hear firsthand the most recent breakthroughs in MF treatment and management and get your most pressing questions answered by MF experts.
Credits Offered
This event offers
0.5 contact hours
to attendees.
Accreditation Info:
AANP.
Additional Information
In the final webinar of the series, expert faculty will discuss the latest evidence from clinical trials in MF to support learners in differentiating novel therapies based on molecular target, clinical data, and potential positioning in care.
Speakers
Professor of Medicine and Oncologic Sciences
University of South Florida College of Medicine
Vice Chair, Malignant Hematology Department
Moffitt Cancer Center
Tampa, FL
Professor of Medicine
Vice Chair, and Section Chief for Hematology
Program Director for the Blood and Marrow Transplant Program
Mayo Clinic
Phoenix, AZ
Clinical Associate Professor, Hematology/Oncology - School of Pharmacy
Associate Professor, Precision Medicine - Graduate School of Biomedical Sciences
The Medical College of Wisconsin
Milwaukee, WI